Track market-moving stories before they get noisy

New York, New York--(Newsfile Corp. - October 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Cooper Companies, Inc. (NASDAQ: COO) resulting from allegations that CooperCompanies may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased CooperCompanies securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/cases/the-cooper-companies-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: On September 10, 2026, The Motley Fool published an article entitled "Why is Cooper Companies Stock Down 15% Today?". The article stated that Cooper Companies stock fell "after the company's earnings report disappointed Wall Street with weak guidance and a decision to not sell Cooper Surgical."

On this news, Cooper Companies' stock fell 14.6% on September 10, 2026.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/318098

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Key Takeaways Archer Aviation outperformed its industry over three months despite a 3.5% share-price decline.Archer is advancing eVTOL commercialization through acquisitions, infrastructure and Midnight flight tests.Archer's strong liquidity supports growth, but its premium valuation may limit near-term upside. Archer Aviation Inc. (ACHR - Free Report) shares have lost 3.5% in the past three months, outperforming the Zacks Aerospace-Defense industry’s decline of 14.8% as well as the broader Zacks Aerospace sector’s loss of 16%. However, it underperformed the S&P 500’s return of 3.7% in the same time frame.

Image Source: Zacks Investment Research

Other industry players, such as Virgin Galactic (SPCE - Free Report) and Embraer (EMBJ - Free Report) , have delivered a similar performance in the past three months. Shares of SPCE and EMBJ have gained 16.2% and 18.9%, respectively, in the said period.

ACHR’s stronger performance compared with the broader aerospace and defense industry, along with gains among key peers, could make the stock appealing to investors. However, investors should assess whether ACHR’s solid fundamentals and growth prospects can sustain long-term gains. Evaluating its growth drivers, earnings outlook and key risks will be crucial in determining the stock’s potential for further upside.

Tailwinds for ACHRArcher Aviation continues to advance its position in the eVTOL market through strategic acquisitions, infrastructure development and successful flight demonstrations aimed at accelerating the commercialization of electric air taxis.

In September 2026, Archer Aviation announced the expiration of the Hart-Scott-Rodino waiting period for its planned acquisition of Boeing’s Wisk Aero, SkyGrid and Insitu subsidiaries. The transaction is expected to close by the end of 2026, subject to remaining regulatory approvals and other customary conditions.

Archer Aviation is also building the infrastructure needed for commercial eVTOL operations. The America’s Consortium for Electric Skyways (ACES), launched by Archer Aviation, BETA Technologies and Macquarie Capital, plans to expand interoperable charging infrastructure across Texas and support up to 250 air taxi sites across major airports and metropolitan areas over the next decade.

Meanwhile, Midnight continues to demonstrate progress toward commercial readiness. In September 2026, the aircraft completed a roughly 40-mile roundtrip flight between Salinas and Hollister, CA, in about 12 minutes each way, reaching speeds of 125 mph. These developments could strengthen Archer Aviation’s commercialization outlook as regulatory support, infrastructure and flight testing continue to advance.

Estimates for ACHR’s 2026 Sales and EarningsThe Zacks Consensus Estimate for ACHR’s 2026 sales implies year-over-year growth of 5467.7%. The consensus estimate for its 2026 losses indicates a year-over-year decline.

Image Source: Zacks Investment Research

The stock’s annual bottom-line estimates have moved north over the past 60 days.

Image Source: Zacks Investment Research

ACHR’s ValuationIn terms of valuation, ACHR’s forward 12-month price-to-sales (P/S) is 30.89X, a premium to the industry average of 2.07X. This suggests that investors will be paying a higher price than the company's expected sales growth compared with its industry average.

Image Source: Zacks Investment Research

Virgin Galactic and Embraer are trading at a discount in comparison with ACHR. SPCE’s forward 12-month price-to-sales is 2.09X, while EMBJ’s forward 12-month price-to-sales is 1.47X.

Liquidity Position of ACHRACHR has a current ratio of 10.21. The ratio, being more than one, indicates that ACHR possesses sufficient capital to pay off its short-term debt obligations.

Its industry peers, Virgin Galactic and Embraer, also maintain current ratios above one. SPCE has a current ratio of 1.62, while EMBJ also holds 1.44.

What Should an Investor Do?ACHR’s demand and healthy liquidity position provide a solid foundation for long-term growth. However, the stock’s premium valuation relative to the industry and key peers may limit its near-term upside potential.

Considering these strengths alongside valuation concerns, existing shareholders may consider holding the stock, while prospective investors could wait for a more attractive entry point. Tracking ACHR’s earnings growth, valuation and execution will remain important when evaluating a new investment.

ACHR currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways Shake Shack plans 40 Brazil locations by 2036, with its first Sao Paulo restaurant set to open in 2027.The Bold Hospitality partnership leverages local expertise and suppliers to support SHAK's Brazil entry.SHAK's Q2 licensing revenues rose 7.1% to $14.2M, supporting its goal of 40-45 licensed openings in 2026. Shake Shack Inc. (SHAK - Free Report) is expanding its footprint in Latin America through a new licensing partnership with Bold Hospitality Company to enter Brazil. The move marks another milestone in the company's international growth strategy, following seven years of operations in Mexico and its planned expansion into Panama.

Brazil has been among Shake Shack's most requested international markets. The planned entry is expected to broaden brand awareness, attract new customers and create additional growth opportunities across the region.

Shake Shack Partners With Bold Hospitality for Brazil ExpansionUnder the agreement, Shake Shack plans to develop 40 locations across Brazil by 2036, with its first restaurant scheduled to open in São Paulo in 2027. The planned rollout is expected to deepen the company's presence in Latin America while creating a new avenue for long-term licensing revenues.

Bold Hospitality Company, a São Paulo-based hospitality operator, brings extensive experience in Brazil's restaurant industry. The company operates brands such as Outback Steakhouse, Abbraccio and Aussie and expects to end 2026 with 217 restaurants across 22 states and the Federal District.

The partnership will combine Shake Shack's premium fast-casual positioning with Bold Hospitality's local market expertise and established restaurant operations. Shake Shack also plans to work with Brazilian producers and suppliers to deliver its signature offerings, including ShackBurger, Chicken Shack, crinkle-cut fries and frozen custard, while incorporating local flavors.

International Expansion Supports SHAK's Growth StrategyThe Brazil agreement aligns with Shake Shack's broader strategy of accelerating global development through licensing partnerships. The company operates more than 740 locations worldwide, including approximately 475 across 36 U.S. states and the District of Columbia and more than 265 international locations.

The licensed business continues to support the company's expansion efforts. In the second quarter of 2026, licensing revenues increased 7.1% year over year to $14.2 million, while total licensing sales rose 7.6% to $222.4 million. Shake Shack opened eight net new licensed restaurants during the quarter and continues to target 40-45 licensed openings for 2026. Management highlighted strong licensed-business performance in Canada, the United Kingdom and parts of China, despite geopolitical disruptions affecting operations in the Middle East.

Shares of SHAK have gained 13.9% in the past three months against the Zacks Retail - Restaurants industry’s 14.9% dip. Shake Shack continues to benefit from restaurant expansion, positive traffic trends, digital engagement and a growing international footprint. However, elevated beef prices, higher operating costs and intense competition remain concerns. Geopolitical instability in the Middle East also continues to pressure licensed operations.

Image Source: Zacks Investment Research

SHAK’s Zacks Rank & Other Key PicksCurrently, Shake Shack carries a Zacks Rank #2 (Buy).

Some other top-ranked stocks from the Zacks Retail-Wholesale sector are:

Five Below, Inc. (FIVE - Free Report) currently sports a Zacks Rank #1 (Strong Buy). The company delivered a trailing four-quarter earnings surprise of 68.3%, on average. FIVE stock has gained 8.5% year to date. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Five Below’s fiscal 2027 sales and EPS indicates growth of 20.1% and 57.6%, respectively, from the year-ago period’s levels.

Cracker Barrel Old Country Store, Inc. (CBRL - Free Report) currently flaunts a Zacks Rank #1. The company delivered a trailing four-quarter earnings surprise of 228.6%, on average. CBRL stock has surged 122% year to date.

 The Zacks Consensus Estimate for Cracker Barrel's 2026 sales and EPS indicates a year-over-year decline of 1% and 81.3%, respectively, from the prior-year levels.

 FIGS, Inc. (FIGS - Free Report) has a Zacks Rank #2 at present. The company delivered a trailing four-quarter earnings surprise of 201.8%, on average. FIGS stock has risen 23.8% year to date.

 The Zacks Consensus Estimate for FIGS’ 2026 sales and EPS indicates growth of 19.8% and 89.5%, respectively, from the prior-year levels.

3 Fresh Stock Buybacks: These are the Ones to BuyHelen of Troy NASDAQ: HELE reported fiscal second-quarter 2027 results that met its sales outlook and exceeded its adjusted earnings expectations, aided by growth in its Home & Outdoor segment, improving cash flow and a net benefit from tariff refunds that the company plans largely to reinvest.

Chief Executive Officer Scott Uzzell said the company remains focused on a multiyear effort to strengthen its operating foundation before pursuing broader growth. “Our recovery will not be linear,” Uzzell said, describing fiscal 2027 as a year for demonstrating progress in brand growth, marketplace execution, organizational capabilities and balance-sheet discipline.

Get Helen of Troy alerts:

Sales growth led by Home & Outdoor Helen of Troy and NanoString Technologies Trade Set-ups Consolidated sales increased 2.1% in the second quarter, in line with management’s outlook. Home & Outdoor sales rose 9.2%, with growth across Osprey, OXO and Hydro Flask. Beauty & Wellness sales declined 4.5%, as growth in wellness and nail care was more than offset by declines across the remainder of the Beauty business.

Uzzell said Osprey again led growth within Home & Outdoor, supported by consumer demand, product introductions and improvements in international distribution. OXO benefited from inventory-composition actions, distribution gains and new products, while Hydro Flask was aided by inventory actions, innovation and a partial recovery of tariff-related disruption in its corporate channel.

Helen Of Troy Is What We Fear Most About Q2 Earnings International sales rose 3.7%, led by Hydro Flask, OXO and Osprey. The company cited new products, expanded distribution and improved execution in selected markets, including a new Australian distributor.

Within Beauty & Wellness, management highlighted growth at Vicks and Braun, supported by distribution gains, comparisons with prior tariff-related items and new products. Olive & June also posted another solid quarter, driven by consumer demand, replenishment orders and new or expanded distribution.

However, Uzzell said some Beauty brands continue to face softer demand and require additional work on commercial execution and demand creation. During the quarter, the company appointed a new leader for the Beauty & Wellness business.

Tariff refunds lift profitability, fund reinvestment Chief Financial Officer Brian Grass said second-quarter results included approximately $26.9 million of gross pretax tariff refunds. After planned reinvestment, the company recorded an estimated net pretax benefit of about $4 million, equal to roughly $0.12 per diluted share after tax.

For the full fiscal year, Helen of Troy expects gross refunds covering the full amount of paid IEEPA tariffs of $80.5 million. The company plans to reinvest between $66.5 million and $70.5 million, resulting in an estimated net pretax benefit of $10 million to $14 million and an adjusted diluted EPS benefit of $0.30 to $0.45.

Management said it intends to use the funds for foundational and longer-term investments, including brand-building, product development, packaging, consumer insights, growth strategy and inventory cleanup. Grass said about 25% of the spending is expected to generate a fiscal 2027 return, while other investments are intended to better position the company for fiscal 2028.

Grass cautioned that the refunds do not fully offset the broader cumulative impact of tariffs. The company has also faced unreimbursed tariffs, supply-chain diversification expenses, longer lead times, disruption to certain revenue streams and higher interest expense associated with cash tariff payments.

Consolidated gross margin increased 800 basis points to 52.2%. The company attributed approximately 560 basis points of the gain to tariff refunds net of higher tariff costs, along with lower retail trade and promotional spending. These benefits were partly offset by inflation in commodities, fuel, freight, currency and supply availability, as well as less favorable inventory obsolescence.

The SG&A ratio increased 540 basis points to 46.4%, reflecting tariff-refund reinvestment, spending on the organization, go-to-market structure and brands, as well as higher packaging costs and divestiture litigation costs. Adjusted EBITDA increased $13.2 million, while adjusted EBITDA margin improved 280 basis points.

Balance sheet improves as inventory and debt decline Helen of Troy generated $56.5 million in cash flow from operations and $38 million in free cash flow during the first half. Inventory ended the quarter at $480 million, down $49 million from a year earlier. The percentage of active inventory improved by seven percentage points in the first half, and management is targeting a 12-percentage-point improvement by year-end.

Total debt fell to $673 million, down $221 million from the prior-year period and $108 million since the beginning of the fiscal year. Net leverage declined to 3.0 times from 3.5 times at the end of the first quarter. The company now expects to end fiscal 2027 with net leverage of 2.7 times or lower.

Full-year outlook revised The company narrowed its fiscal 2027 net sales outlook to $1.768 billion to $1.822 billion. It expects Home & Outdoor sales of $851 million to $876 million and Beauty & Wellness sales of $917 million to $946 million.

Base-business adjusted EBITDA guidance was maintained at $193 million to $196 million. Consolidated adjusted EBITDA guidance was raised to $203 million to $210 million, including the net tariff-refund benefit. Base-business adjusted EPS guidance was narrowed to $3.30 to $3.70. Consolidated adjusted EPS guidance was raised to $3.60 to $4.15. Free cash flow guidance was raised to $120 million to $140 million, despite a $9 million increase in planned capital expenditures. For the third quarter, Helen of Troy expects sales of $478.3 million to $504.5 million and consolidated adjusted EPS of $2.05 to $2.40. That estimate includes a projected tariff-refund benefit of $0.66 to $0.77 per share, as the company expects to recognize its remaining $51.8 million in gross IEEPA tariff refunds during the quarter.

Management said the outlook reflects continuing inflationary and supply-disruption risks related largely to conflict in the Middle East, as well as elevated fuel costs, higher interest and mortgage rates, discretionary-category softness, cautious retailer inventory management and a more promotional competitive environment.

Uzzell said the company remains confident in its strongest brands but expects a challenging consumer environment. He said Hydro Flask faces a more saturated and promotional beverageware market, while management seeks to maintain the brand’s premium positioning through consumer messaging, product innovation and expansion into adjacent categories.

About Helen of Troy (NASDAQ:HELE)Helen of Troy Limited is a global consumer products company that develops, markets and distributes branded products across the home and outdoor, beauty, and health and wellness categories. Its portfolio includes household and organization products, drinkware and outdoor equipment, personal-care appliances, hair-care products, and consumer health products.

The company's principal brands include OXO, Hydro Flask, Osprey, Drybar and Hot Tools. Helen of Troy also markets certain health and wellness products under licensed brands, including Vicks, Braun and Honeywell, as well as beauty products under selected licensed and owned brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Helen of Troy Right Now?Before you consider Helen of Troy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Helen of Troy wasn't on the list.

While Helen of Troy currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Wall Street analysts forecast that Domino's Pizza (DPZ - Free Report) will report quarterly earnings of $4.33 per share in its upcoming release, pointing to a year-over-year increase of 6.1%. It is anticipated that revenues will amount to $1.17 billion, exhibiting an increase of 1.6% compared to the year-ago quarter.

Over the last 30 days, there has been an upward revision of 1.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.

Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.

While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.

Given this perspective, it's time to examine the average forecasts of specific Domino's Pizza metrics that are routinely monitored and predicted by Wall Street analysts.

It is projected by analysts that the 'Revenues- U.S. franchise advertising' will reach $132.10 million. The estimate suggests a change of +0.4% year over year.

The consensus estimate for 'Revenues- U.S. Company-owned stores' stands at $64.40 million. The estimate points to a change of -22.2% from the year-ago quarter.

Based on the collective assessment of analysts, 'Revenues- Supply chain' should arrive at $725.99 million. The estimate suggests a change of +4.2% year over year.

According to the collective judgment of analysts, 'Revenues- International franchise royalties and fees' should come in at $78.51 million. The estimate points to a change of -0.1% from the year-ago quarter.

Analysts forecast 'Store counts - Total U.S. Stores' to reach 7,263 . Compared to the current estimate, the company reported 7,090 in the same quarter of the previous year.

The combined assessment of analysts suggests that 'Same store sales growth - U.S. stores' will likely reach 1.1%. The estimate compares to the year-ago value of 5.2%.

The consensus among analysts is that 'Store counts - Total' will reach 22,740 . Compared to the present estimate, the company reported 21,750 in the same quarter last year.

The collective assessment of analysts points to an estimated 'Store counts - International Stores' of 15,477 . Compared to the present estimate, the company reported 14,660 in the same quarter last year.

The average prediction of analysts places 'Store counts - U.S. Franchise Stores' at 7,075 . The estimate compares to the year-ago value of 6,830 .

Analysts expect 'Store counts - U.S. Company-owned Stores' to come in at 188 . Compared to the current estimate, the company reported 260 in the same quarter of the previous year.

Analysts' assessment points toward 'Store counts - Opened - International Stores' reaching 217 . Compared to the present estimate, the company reported 220 in the same quarter last year.

Analysts predict that the 'Store counts - Opened - Total U.S. stores' will reach 33 . The estimate compares to the year-ago value of 30 .

View all Key Company Metrics for Domino's Pizza here>>>

Shares of Domino's Pizza have experienced a change of -5.7% in the past month compared to the +1.4% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), DPZ is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Key Takeaways Pagaya raised $3.7B across six ABS deals in Q2'26 and added 11 institutional investors.PGY secured major auto, personal-loan and receivables facilities to broaden funding flexibility.Pagaya's 2026 ABS issuance topped $9B, showing securitization remains central to its funding model. Pagaya Technologies (PGY - Free Report) is steadily broadening its funding base, which could make its capital model more resilient. In second-quarter 2026, it raised $3.7 billion across six asset-backed securities (ABS) transactions and added 11 new institutional investors, taking the total to 174. At the same time, the company is expanding committed-capital structures outside traditional securitization markets, improving funding flexibility and visibility.

Recent transactions reinforce this shift. Pagaya secured up to $700 million in auto funding from Neuberger Specialty Finance, a nearly $700-million Variable Funding Note facility with ATLAS SP Partners and a $460-million revolving personal-loan facility expected to support about $850 million in capital deployment. It also expanded its ALPF receivables facility to $100 million. Together, these arrangements broaden funding flexibility and reduce reliance on the timing of public securitizations.

That flexibility could become increasingly important as Pagaya scales across personal loans, auto and point-of-sale financing. Its auto business reached an annualized network-volume run rate of $4.8 billion in the second quarter, while total quarterly network volume was $3.5 billion. Management has indicated that a growing portion of funding now comes through non-prefunded structures, including forward-flow and revolving arrangements. A broader mix of committed funding sources could help Pagaya better match different asset classes with different pools of institutional capital and reduce execution risk during periods when securitization spreads widen or investor demand weakens.

However, the company is not moving away from ABS in any meaningful sense yet. A few days ago, Pagaya completed a $600-million AAA-rated personal-loan securitization, lifting 2026 ABS issuance to more than $9 billion, including more than $6 billion tied to personal loans. The transaction drew 47 investors, including three new participants, underscoring continued demand for Pagaya-backed assets. Importantly, some of the newer funding structures are designed to bridge loans into eventual securitizations, meaning they can support the ABS model rather than substitute for it.

Hence, Pagaya appears to be building a more diversified funding architecture rather than replacing securitization. Forward-flow agreements, revolving facilities and warehouse-style structures should improve capital availability and reduce funding concentration risk, which is constructive for growth and execution. Still, record ABS issuance shows that securitization remains a core funding engine.

Comparing Pagaya’s Business Model With PeersLike PGY, Upstart Holdings, Inc. (UPST - Free Report) is an artificial intelligence (AI)-based lending platform that aspires to become capital-light but often holds loans on its balance sheet temporarily. The company’s core business model involves finding financing for loans after its network of bank and institutional partners originates them.

Upstart partner banks can finance the loan by keeping it on their balance sheet. The bank can sell the whole loan on Upstart’s platform or use forward flow agreements from institutions that commit to buying a specific volume or type of loan originated on the Upstart platform in the future.

Upstart also uses securitization, wherein pools of loans are bundled together and sold as ABS to institutional investors. However, the firm frequently reverts to a balance-sheet-heavy model, especially in tight liquidity markets, making it more volatile and exposed to macro cycles.

Another close competitor of PGY is LendingTree (TREE - Free Report) . But unlike PGY, LendingTree is a marketplace platform, not a lender. It matches consumers with financial product providers like mortgages, personal loans, credit cards and insurance.

LendingTree does not underwrite, originate or hold loans. Hence, its balance sheet is not credit-heavy. TREE’s balance sheet is detached from revenue generation. The company is primarily structured to support a fee-based digital marketplace, not balance sheet lending.

PGY’s Price Performance, Valuation & Estimate AnalysisOver the past six months, Pagaya shares have gained 51.9%, outperforming the industry’s growth.

Image Source: Zacks Investment Research

The stock is currently trading at a 12-month forward price-to-sales of 0.94X, which is below the industry average of 2.70X.

Image Source: Zacks Investment Research

Over the past seven days, the Zacks Consensus Estimate for PGY’s 2026 and 2027 earnings has been unchanged at $3.68 and $4.13, respectively. The consensus estimate indicates 11.2% and 12.2% year-over-year growth for 2026 and 2027, respectively.

Image Source: Zacks Investment Research

Nebius has already signed tens of billions in AI compute contracts, crushed revenue estimates, and handed investors a triple-digit return this year, but its balance sheet carries threats that could unwind everything before 2027 arrives.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Nebius Group (NASDAQ:NBIS | NBIS Price Prediction) trades at $237.15. The AI cloud provider is converting a $37.49 billion contract backlog into revenue rapidly, giving investors direct exposure to AI compute demand outside mega caps.

Nebius leases GPU compute, storage and inference tools through Nebius AI Cloud, which produced 98% of group revenue last quarter. Anchor contracts include a $27 billion five-year Meta Platforms (NASDAQ:META) agreement and a Microsoft (NASDAQ:MSFT) deal valued at $17.4 billion to $19.4 billion. NVIDIA (NASDAQ:NVDA) committed $2 billion strategically. Shares are up 183.32% year to date but fell 5.09% in the latest session.

A Sold-Out Cloud With Rising Prices Points Higher Second-quarter revenue rose 454% to $582.3 million, beating the $574.65 million consensus. Group adjusted EBITDA came in at $236 million with a 41% margin versus a $21 million loss a year earlier. Management confirmed its $7 billion to $9 billion ARR target for 2026 and raised its year-end contracted power goal to 5 gigawatts.

Pricing power is growing. The company’s first capacity auction cleared 15% above its previous top price. At a forward P/E of 46 and consensus 2027 revenue of roughly $12.3 billion, the valuation leans on expected growth.

Billions in Capex and Convertible Debt Threaten Shareholders Nebius posted a GAAP net loss of $190.4 million. Consensus EPS is -$2.2773 for 2026 and -$5.6426 for 2027. Capex guidance is $20 billion to $25 billion, and quarterly interest expense rose to $119.1 million from $4.8 million.

Convertible debt has a fair value of $20.8 billion against a $8.5 billion carrying amount, which points to heavy potential dilution. Three customers made up for 24%, 21%, and 14% of revenue. In the first quarter, revenue fell short of estimates by 32.74%. At 50 times sales, the stock cannot afford another miss.

Third-Quarter Results Will Test Whether Growth Can Fund Itself The case for patience rests on operations working while profits remain a forecast. Nebius sells out new capacity as it comes online and expects more than $9 billion in customer prepayments this year. GAAP losses continue, though, and the company carries $12.1 billion in future lease obligations.

Consensus calls for about $904 million in third-quarter revenue. A beat and solid 2027 outlook would strengthen the bull case. A miss or new convertible offering would strengthen the bear case.

Wall Street Sees Upside After a Market-Beating Run Nebius trades at $237.15. The consensus target of $282.53 implies 19.1% upside. Price targets are uncertain, and this one reflects 10 analysts:

Strong Buy: 2 Buy: 6 Hold: 1 Sell: 1 The stock has gained 101.49% over the past year versus 16.16% for the S&P 500. Year to date, Nebius is up 183.32% compared with a gain of 13.98% for the index. Momentum has slowed. Over the past week, Nebius gained 0.54% versus 1.92% for the index. Shares remain below their 52-week high of $299.86.

Nebius Faces Its Biggest Test as 2027 Pricing Comes Into Focus At $237.15, Nebius trades below its consensus target.

The path to a higher stock price runs through the next three quarters. Capacity installed late in the second quarter starts adding revenue in the third. Deals signed at yields above $20 million per megawatt, with payback periods under two years, start coming online in late Q4. Vera Rubin systems should begin deploying in late 2026 or early 2027.

Customer prepayments cover 50% to 60% of related capex, reducing the need for new equity. With shares trading well below their high as margins expand, the outlook depends on execution.

The thesis fails if third-quarter revenue misses, a top customer pulls back or Nebius issues another large convertible. Watch progress toward the ARR target.

Nebius offers scaled, pure-play access to AI compute demand outside the chipmakers, and the current price reflects a backlog of more than $37 billion (we featured seven other non-chipmaker suppliers riding the same expansion, accessible without charge at here).

Contact [email protected] for any questions or corrections.

Key Takeaways APLD's $36B contracted revenue base spans 1.41 GW across five campuses, backed by long-term leases.APLD expects over 600 MW online within 12 months, following a 322% surge in fiscal first-quarter revenues.APLD faces financing and construction risks, while Core Scientific and TeraWulf intensify competition. Applied Digital (APLD - Free Report) has a substantial foundation for long-term growth from its $36 billion contracted revenue base, provided it can convert contracted capacity into operating assets and recurring revenues. As of Aug. 31, 2026, APLD had approximately 1.41 GW of contracted critical IT load across five campuses, representing about $36 billion of contracted revenues over initial base terms. The portfolio is backed by CoreWeave and investment-grade hyperscalers, with leases generally structured for 15 years and on a take-or-pay basis.

The company is beginning to demonstrate this conversion. Polaris Forge 1 reached 250 MW of operational capacity on Oct. 1, while APLD expects to place more than 600 MW into service over the next 12 months. First-quarter fiscal 2027 revenues surged 322% year over year to $341.9 million, while HPC Hosting generated $262.6 million, including $65.8 million of base rent.

However, investors should not equate the backlog with immediately realized revenues. Much of the contracted capacity remains under construction, while APLD had $6.4 billion of debt and $3.7 billion in cash, cash equivalents and restricted cash at quarter-end. Customer concentration and construction and financing requirements remain important risks.

Overall, APLD's $36 billion contracted revenue base can support long-term growth, but sustained growth depends on successfully financing, completing and bringing contracted AI capacity online while increasing recurring base-rent revenues. The growth outlook is also reflected in the Zacks Consensus Estimate, which projects for fiscal 2027 and 2028 revenue growth of 49.67% and 107.93%, respectively, underscoring the potential for APLD's expanding AI infrastructure portfolio to translate its contracted revenue base into substantial top-line growth.

APLD Faces Stiff Competition in Contracted Revenue BaseCore Scientific (CORZ - Free Report) is narrowing APLD’s contracted-revenue lead, with more than $24 billion in contracted revenues and about 1.1 GW of contracted capacity. Core Scientific also added an AMD agreement representing over $14 billion of base contracted revenues across 15 years. With expansion potential beyond current commitments, Core Scientific presents a growing contracted-revenue challenge to APLD.

TeraWulf (WULF - Free Report) , meanwhile, is building substantial contracted visibility, reporting roughly $27 billion of contracted revenues and 839 MW of leased capacity. TeraWulf’s 401-MW Anthropic lease contributes approximately $19 billion over 20 years, and the company targets another 250-500 MW of annual contracted capacity growth. This combination gives TeraWulf a credible path to challenge APLD’s contracted-revenue growth narrative.

APLD’s Share Price Performance, Valuation & EstimatesShares of APLD have lost 2.9% year to date, underperforming the broader Zacks Finance sector’s 4.2% rise.

APLD’s YTD Price Performance
Image Source: Zacks Investment Research

From a valuation standpoint, APLD trades at a trailing twelve-month price-to-book (P/B) ratio of 4.02, higher than the Finance – Miscellaneous Services industry’s 2.96. The company carries a Value Score of F. A price-to-book ratio above 1.0 means the stock is trading at a premium to its accounting net worth.

APLD’s Valuation
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Applied Digital’s fiscal 2027 bottom line is currently pegged at a loss of $1.09 per share, unchanged over the past 30 days. The projected loss is wider than the 91-cent loss recorded a year ago.

Image Source: Zacks Investment Research

Key Takeaways CoreWeave is entering India with 240 MW of AI data center capacity at AdaniConneX's Taloja campus.The project includes three 80 MW buildings, with the first phase expected to be operational in mid-2028.CoreWeave plans to deploy NVIDIA Vera Rubin, targeting agentic AI and inference workloads in India. CoreWeave, Inc. (CRWV - Free Report) recently took a major step in its global expansion strategy by entering India, announcing plans to develop 240 MW of AI data center capacity through a collaboration with AdaniConneX at its Taloja campus in Navi Mumbai. The move comes as demand for AI computing infrastructure accelerates globally and India emerges as a booming market for AI development, cloud computing and data center investment. The expansion is likely to be a key growth catalyst for CoreWeave, but its benefits will depend on how quickly the company can bring capacity online, secure customers and monetize increasingly powerful AI infrastructure.

Per the deal, the initial deployment will consist of three 80 MW buildings, with CoreWeave serving as the sole tenant. The campus also has the potential to double capacity by another 240 MW, giving the company a possible total expansion opportunity of 480 MW. The first phase is expected to become operational in mid-2028, with additional capacity coming online in phases. A key aspect of the announcement is its plan to deploy the NVIDIA Vera Rubin Platform. Recently, CRWV expanded beyond GPUs with NVIDIA Vera and Vera Rubin, targeting agentic AI and inference workloads while deepening its infrastructure strategy. Deploying next-generation NVIDIA infrastructure in India could give customers access to advanced AI computing without requiring them to make massive upfront infrastructure investments.

CoreWeave has been aggressively building a global footprint across North America, Europe and the Asia-Pacific. The company's entry into Indonesia in August represents another step in that strategy. As stated on its second-quarter earnings call, CoreWeave has approximately 4.2 GW of contracted power. The India project is likely to fit into a broader strategy of secure power, build specialized data centers, deploy advanced NVIDIA hardware and provide AI infrastructure close to customers. The model can create a powerful competitive position if CoreWeave maintains high utilization and attractive pricing.

Mapping CRWV’s Competitive LandscapeNebius Group (NBIS - Free Report) recently acquired Inferize to strengthen production inference capabilities within Token Factory. Inferize aims to cut cold-start delays, reduce idle GPU time and improve capacity utilization. The deal adds GPU systems expertise as Nebius expands inference and post-training workloads. It plans to invest £1.7 billion in U.K. AI infrastructure, adding three advanced NVIDIA-powered deployments to support growing AI demand. NBIS recently partnered with Palantir for AI-native cloud infrastructure. Under the agreement, Nebius will provide AI compute and inference infrastructure to Palantir’s commercial customers. NBIS expects connected power capacity to reach roughly 800 MW to 1 GW by 2026 end.

Microsoft (MSFT - Free Report) continued expanding its partnerships across AI, cloud and enterprise technology. The company broadened its decade-long partnership with Databricks into the 2030s, while expanding ties with Mistral to bring its models across Microsoft Foundry, Copilot Studio and Azure. Microsoft also partnered with 3M on AI data-center infrastructure and enterprise transformation, with Azure set to deploy 3M’s Expanded Beam Optical technology. Its partnership with NASA entails applying AI tools to scientific data discovery. Microsoft also struck an AI content agreement with Nine Entertainment, allowing Copilot to reference its journalism, while its OpenAI relationship continues under an IP arrangement extending to 2032.

CRWV Price Performance, Valuation and EstimatesShares of CoreWeave have gained 23.5% year to date compared with the Internet Software industry’s rise of 7.6%.

Image Source: Zacks Investment Research

On a price-to-book basis, CRWV’s shares trade at 8.08X, higher than the Internet Software industry’s 5.44X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for CRWV’s earnings for the current year has been revised downward over the past 60 days.

Image Source: Zacks Investment Research

CRWV currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

HWG Holdings LP bought a new position in Sandisk Corporation (NASDAQ:SNDK – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,666 shares of the data storage provider’s stock, valued at approximately $2,899,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Venture Visionary Partners LLC boosted its holdings in Sandisk by 12.4% in the 3rd quarter. Venture Visionary Partners LLC now owns 752 shares of the data storage provider’s stock valued at $1,310,000 after purchasing an additional 83 shares in the last quarter. Elm3 Financial Group LLC boosted its stake in shares of Sandisk by 302.3% in the third quarter. Elm3 Financial Group LLC now owns 688 shares of the data storage provider’s stock valued at $1,197,000 after buying an additional 517 shares in the last quarter. Wealth Enhancement Trust Services Inc. grew its holdings in Sandisk by 1,463.6% during the third quarter. Wealth Enhancement Trust Services Inc. now owns 3,221 shares of the data storage provider’s stock worth $5,604,000 after acquiring an additional 3,015 shares during the period. PFW Advisors LLC raised its position in Sandisk by 4.4% in the third quarter. PFW Advisors LLC now owns 262 shares of the data storage provider’s stock worth $456,000 after acquiring an additional 11 shares in the last quarter. Finally, Lake Hills Wealth Management LLC lifted its holdings in Sandisk by 16.5% in the third quarter. Lake Hills Wealth Management LLC now owns 438 shares of the data storage provider’s stock valued at $762,000 after acquiring an additional 62 shares during the period.

Insider Activity In other news, CEO David Goeckeler sold 33,841 shares of Sandisk stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $1,574.21, for a total transaction of $53,272,840.61. Following the completion of the sale, the chief executive officer directly owned 382,865 shares in the company, valued at $602,709,911.65. The trade was a 8.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Bernard Shek sold 2,308 shares of the business’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $1,767.33, for a total transaction of $4,078,997.64. Following the completion of the transaction, the insider directly owned 25,305 shares of the company’s stock, valued at approximately $44,722,285.65. This represents a 8.36% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 77,899 shares of company stock worth $121,159,122. Company insiders own 0.21% of the company’s stock.

Wall Street Analysts Forecast Growth A number of equities analysts have recently weighed in on the stock. Wells Fargo & Company upped their price target on shares of Sandisk from $1,400.00 to $1,550.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 13th. Arete Research increased their target price on shares of Sandisk from $2,300.00 to $3,000.00 and gave the company a “buy” rating in a report on Thursday, August 27th. China Renaissance boosted their price target on Sandisk from $2,000.00 to $2,250.00 and gave the stock a “buy” rating in a research note on Wednesday, August 19th. Royal Bank Of Canada raised their price objective on Sandisk from $1,300.00 to $1,600.00 and gave the company a “sector perform” rating in a research note on Friday, August 14th. Finally, Citigroup reiterated a “buy” rating on shares of Sandisk in a research report on Thursday, October 1st. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $2,120.65. Get Our Latest Stock Report on SNDK

Key Headlines Impacting Sandisk Here are the key news stories impacting Sandisk this week:

Positive Sentiment: AI demand is reshaping the memory market. Analysts argue that data-center and artificial-intelligence infrastructure demand may make the current memory upcycle more durable than traditional memory cycles. Sandisk’s large contract backlog and long-term customer commitments reinforce this view. Memory Trade: Cyclical or Durable Growth Positive Sentiment: Tight supply is supporting pricing and investor interest. Sandisk and Micron have outperformed a softer technology market as memory producers reportedly secure output through advance contracts. Sandisk’s data-center revenue rose sharply through fiscal 2026, highlighting hyperscaler demand as a key growth driver. Tight Memory Supply Outruns a Softer Tech Tape Positive Sentiment: Mizuho raised its Sandisk price target to $2,050 from $1,875 and maintained an Outperform rating, citing demand from agentic AI applications. Zacks also included SNDK on its Strong Buy and momentum-stock lists. Mizuho Raises Sandisk Stock Price Target Positive Sentiment: A substantial contract book and customer funding provide visibility. Sandisk reportedly has a $93.9 billion non-binding memorandum contract book, backed by financial guarantees and customer prepayments, while underlying free cash flow remains strong. A buyback may provide additional shareholder support. Sandisk Customer Money Is Keeping Pace With the Contract Boom Neutral Sentiment: Trading has been highly volatile. Sandisk initially moved lower alongside Micron and SK Hynix as investors took profits after a major rally and focused on upcoming earnings and sector reporting risk. The subsequent recovery suggests investors continue to favor the company’s AI exposure, but expectations are elevated. Memory Stocks Extend Losses in Premarket Negative Sentiment: Valuation and dependence on memory pricing remain risks. Commentary notes that Sandisk’s growth is heavily reliant on favorable pricing, while its steep 2026 advance leaves the stock vulnerable to profit-taking if supply conditions weaken or AI spending slows. Which AI Memory Stock Has More Room to Run? Sandisk Price Performance Shares of Sandisk stock opened at $1,692.42 on Thursday. Sandisk Corporation has a 1 year low of $116.17 and a 1 year high of $2,354.39. The business has a 50 day moving average price of $1,579.07 and a 200 day moving average price of $1,463.49. The company has a market capitalization of $247.80 billion, a P/E ratio of 23.22, a P/E/G ratio of 0.17 and a beta of 5.23.

Sandisk (NASDAQ:SNDK – Get Free Report) last announced its earnings results on Wednesday, August 5th. The data storage provider reported $39.25 EPS for the quarter, beating analysts’ consensus estimates of $33.28 by $5.97. Sandisk had a return on equity of 87.84% and a net margin of 56.47%.The firm had revenue of $8.96 billion for the quarter. During the same quarter last year, the company posted $0.29 EPS. Sandisk’s quarterly revenue was up 371.6% compared to the same quarter last year. Sandisk has set its Q1 2027 guidance at 44.000-46.000 EPS. As a group, research analysts expect that Sandisk Corporation will post 208.94 EPS for the current fiscal year.

Sandisk declared that its Board of Directors has authorized a stock buyback plan on Wednesday, August 5th that allows the company to repurchase $14.00 billion in shares. This repurchase authorization allows the data storage provider to repurchase up to 6.6% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board believes its stock is undervalued.

About Sandisk (Free Report)

SanDisk Corporation offers flash storage solutions. The Company designs, develops and manufactures data storage solutions in a range of form factors using flash memory, controller, firmware and software technologies. The Company operates through flash memory storage products segment. Its solutions include a range of solid state drives (SSD), embedded products, removable cards, universal serial bus (USB), drives, wireless media drives, digital media players, and wafers and components. It offers SSDs for client computing applications, which encompass desktop computers, notebook computers, tablets and other computing devices.

Read More Five stocks we like better than Sandisk Skydance Just Became a Media Giant—With an $80 Billion Debt Load Could Velo3D Be the Next Defense Buyout Target? Penguin Solutions Is Soaring as AI Memory Demand Explodes Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up

Receive News & Ratings for Sandisk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandisk and related companies with MarketBeat.com's FREE daily email newsletter.

Ayalon Insurance Comp Ltd. grew its holdings in shares of Uber Technologies, Inc. (NYSE:UBER – Free Report) by 345.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,071 shares of the ride-sharing company’s stock after acquiring an additional 21,000 shares during the period. Ayalon Insurance Comp Ltd.’s holdings in Uber Technologies were worth $1,855,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Public Investment Fund acquired a new stake in Uber Technologies during the 2nd quarter valued at approximately $5,256,173,439. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Uber Technologies by 2.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,078,612 shares of the ride-sharing company’s stock valued at $1,068,653,000 after buying an additional 258,448 shares during the last quarter. Legal & General Group Plc acquired a new stake in shares of Uber Technologies during the second quarter worth approximately $943,167,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Uber Technologies in the second quarter worth $752,151,000. Finally, Baird Financial Group Inc. increased its stake in shares of Uber Technologies by 64.4% in the second quarter. Baird Financial Group Inc. now owns 9,099,343 shares of the ride-sharing company’s stock worth $656,609,000 after buying an additional 3,564,073 shares during the last quarter. 80.24% of the stock is owned by hedge funds and other institutional investors.

Key Uber Technologies News Here are the key news stories impacting Uber Technologies this week:

Positive Sentiment: Uber agreed to acquire workplace-catering platform ezCater in an all-cash transaction. The deal would add access to more than 140,000 U.S. restaurants, approximately $2.5 billion in annual gross bookings and average orders above $400, potentially improving Uber Eats’ order economics and expanding Uber for Business. Uber To Acquire ezCater For $2.3 Billion Positive Sentiment: Analysts and bullish commentary suggest the ezCater transaction, alongside Uber’s planned Delivery Hero investment, could add roughly $66 billion in bookings and push 2027 bookings above $340 billion, with projected EBITDA potentially reaching $16.6 billion. Uber Technologies: Delivery Hero, ezCater Acquisition Should Push 2027 Bookings To Over $340B Positive Sentiment: Citizens JMP reaffirmed a “market outperform” rating and a $100 price target, implying substantial upside from current levels. Separate analysis points to strong bookings momentum that may be underappreciated by the market. Neutral Sentiment: Uber has settled a third bellwether sexual-assault lawsuit. The resolution removes one legal matter, but the broader litigation and related reputational risks remain relevant to investors. Uber Technologies Settles Third Bellwether Sexual Assault Lawsuit Negative Sentiment: Retail investors have criticized the ezCater purchase, questioning whether Uber is paying too much and whether management can integrate another major business while pursuing other acquisitions. That skepticism appears to be limiting the stock’s response to the announcement. UBER Stock In Focus: Uber’s $2.3B Bet On ezCater Fails To Lift Retail Mood Negative Sentiment: A study reportedly found Uber riders are paying 53% more while waiting 19% longer, raising concerns about affordability, service reliability and potential pressure on ride demand. Uber Technologies Price Performance Shares of NYSE:UBER opened at $68.41 on Thursday. The company has a market cap of $139.73 billion, a PE ratio of 15.04, a P/E/G ratio of 5.63 and a beta of 1.27. Uber Technologies, Inc. has a fifty-two week low of $65.41 and a fifty-two week high of $100.35. The firm has a 50-day simple moving average of $73.15 and a 200 day simple moving average of $72.98. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.38. Uber Technologies (NYSE:UBER – Get Free Report) last posted its earnings results on Wednesday, August 5th. The ride-sharing company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.80 by $0.01. Uber Technologies had a return on equity of 43.36% and a net margin of 17.34%.The company had revenue of $14.19 billion during the quarter, compared to analyst estimates of $14.24 billion. During the same period in the prior year, the company earned $0.60 earnings per share. The business’s revenue was up 12.2% compared to the same quarter last year. Uber Technologies has set its Q3 2026 guidance at 0.840-0.880 EPS. On average, sell-side analysts anticipate that Uber Technologies, Inc. will post 3.35 EPS for the current year.

Analyst Ratings Changes A number of research analysts have commented on the stock. Citigroup reiterated a “market outperform” rating on shares of Uber Technologies in a research note on Wednesday. Scotiabank began coverage on shares of Uber Technologies in a research note on Wednesday, September 9th. They issued a “sector outperform” rating and a $100.00 target price on the stock. Cantor Fitzgerald decreased their price target on Uber Technologies from $98.00 to $90.00 and set an “overweight” rating for the company in a research note on Thursday, August 6th. Wells Fargo & Company boosted their price objective on Uber Technologies from $89.00 to $92.00 and gave the company an “overweight” rating in a report on Monday. Finally, Weiss Ratings downgraded Uber Technologies from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, September 21st. Two equities research analysts have rated the stock with a Strong Buy rating, thirty-four have issued a Buy rating, four have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $103.11.

View Our Latest Stock Report on UBER

Insider Transactions at Uber Technologies In other news, insider Andrew Macdonald purchased 70,000 shares of the company’s stock in a transaction on Friday, September 4th. The shares were bought at an average price of $75.83 per share, for a total transaction of $5,308,100.00. Following the completion of the purchase, the insider owned 426,320 shares of the company’s stock, valued at $32,327,845.60. This trade represents a 19.65% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jill Hazelbaker sold 28,170 shares of the business’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $71.31, for a total value of $2,008,802.70. Following the transaction, the insider owned 149,525 shares of the company’s stock, valued at approximately $10,662,627.75. This represents a 15.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 3.81% of the company’s stock.

Uber Technologies Company Profile (Free Report)

Uber Technologies, Inc (NYSE: UBER) is a technology company that operates a global platform connecting consumers with independent drivers, delivery couriers, merchants and other service providers. Founded in 2009 and headquartered in San Francisco, Uber originally focused on app-based ride-hailing and has expanded into a broader range of mobility and delivery services.

Its Mobility segment offers rides through products such as UberX, Uber Black and other locally available options, as well as services including taxis, car rentals, scooters and bikes in select markets.

Further Reading Five stocks we like better than Uber Technologies Skydance Just Became a Media Giant—With an $80 Billion Debt Load Could Velo3D Be the Next Defense Buyout Target? Penguin Solutions Is Soaring as AI Memory Demand Explodes Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up Want to see what other hedge funds are holding UBER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Uber Technologies, Inc. (NYSE:UBER – Free Report).

Receive News & Ratings for Uber Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uber Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

While most people know Google parent Alphabet (GOOG -0.02%)(GOOGL -0.04%) is a key player in the artificial intelligence industry, most investors also know that search-based advertising -- via Google -- remains its bread-and-butter business.

Still, it's tough to ignore the fact that Google Cloud's sales are soaring. They rose 82% year over year to $24.8 billion during the second quarter, and plenty more cloud revenue is already lined up. CEO Sundar Pichai said during the Q2 conference call that Google Cloud's backlog of future business stood at $514 billion.

Is it time to rethink what Alphabet is? Not quite. But it wouldn't be wrong to put the possibility on your longer-term radar.

Google CEO Sundar Pichai. Image source: Alphabet.

If nothing else, faster growth The graphics below tell the tale. Search advertising is by far still the company's single-biggest source of revenue, accounting for more than half of Q2's total top line of $119.8 billion (and more than two-thirds of the quarter's sales when counting YouTube and its ad business within Google's broader network). Cloud computing, conversely, accounted for roughly one-fifth of Alphabet's total revenue. But it's undeniable that cloud computing is the company's fastest-growing arm.

Data source: Alphabet. Chart by author.

Cloud computing -- where the company reports most of its artificial intelligence-related results -- is also growing its profitability at an even faster clip. While last quarter's cloud operating income of $8.8 billion was only slightly less than 22% of the company's total operating income of just under $40.8 billion, it was also up more than 200% from cloud-based operating income of $2.8 billion reported for the second quarter of 2025.

Data source: Alphabet. Chart by author. Note that the "other bets" and "corporate" segments, both of which routinely report operating losses, are excluded.

Moreover, another $514 billion worth of future cloud computing revenue has already been lined up. At its current pace, that's more than five years' worth of cloud sales just waiting to be booked.

Yes and no, but not the point either way So in answer to the question, cloud still isn't anywhere near the profit center to Alphabet that Google search and its related/branded services are. However, cloud computing will likely account for a slight majority of the company's operating income growth for the foreseeable future.

Google Services' operating income improved by $6.5 billion year over year in Q2, for perspective, while Google Cloud's grew by $6 billion. With its cloud arm now operating at scale and its profit margins widening at a brisk pace, continued strength in artificial intelligence promises a major positive impact on net profit growth from here.

Premium Feature

Moneyball Superscore

93/100

Today's Change

(

-0.04

%) $

-0.15

Current Price

$

350.35

Just don't get so enamored by the specific numbers that you lose sight of the bigger picture. That is, Alphabet remains an incredible growth stock precisely because it's a leading name on multiple fronts. And it would be a promising investment even if its AI-led cloud business wasn't making quite as big an impact on its top- and bottom-line growth.

Isomorphic Labs, the artificial intelligence (AI) drug discovery startup spun out of Alphabet Inc (NASDAQ:GOOG)'s Google DeepMind, is in early talks to raise new funding at a valuation of at least $40 billion.

The London-based company could be valued as high as $50 billion in the financing, although the talks are ongoing and terms could change before any deal closes, a report by Bloomberg said.

The potential valuation would represent a sharp increase from just five months ago, when Isomorphic Labs raised $2.1 billion in a Series B funding round that included substantial backing from Alphabet.

Isomorphic Labs was founded in 2021 to build on AlphaFold, DeepMind’s AI system for predicting the three-dimensional structures of proteins, a capability that can help researchers understand how potential medicines interact with biological targets.

The startup is competing with technology companies and biotechnology firms seeking to use AI to reduce the time and cost of discovering and developing new drugs.

Few AI drug discovery companies have yet progressed treatments into clinical trials, and none has brought an AI-designed medicine to market, highlighting the long development timelines and risks involved.

Chief executive Demis Hassabis, who is also Alphabet’s chief scientist and chairman of DeepMind, has said he wants to reduce the time required to develop new medicines from years to months.

Isomorphic Labs has established partnerships with Eli Lilly and Novartis to apply its drug discovery technology to pharmaceutical research, while also developing medicines internally.

The company has said it is focusing on areas including cancer and immune disorders as it seeks to turn its artificial intelligence models into potential treatments.

Hassabis shifted from leading DeepMind to a chairman role in August while remaining chief executive of Isomorphic Labs.

The latest fundraising discussions underscore the growing investor interest in AI applications beyond software, with drug discovery emerging as one of the technology’s potential high-value uses.

Amazon (AMZN -0.58%) is one of the great companies of our generation, and today it is a leader in both e-commerce and cloud computing. While the stock has lagged the market over the past five years, it has laid the foundation for strong growth over the next decade, setting it up for significant gains. With just over $10,000, you could buy 40 shares.

Amazon's biggest source of growth will come from its cloud computing unit, Amazon Web Services (AWS). Amazon created the infrastructure-as-a-service concept and continues to have the largest market share in the cloud computing space today. The unit is its most profitable and also its fastest-growing. Last quarter, AWS revenue climbed 37% to $42.2 billion, while segment operating income soared 63% to $16.6 billion.

Image source: The Motley Fool.

Amazon CEO Andy Jassy sees AWS becoming a $1-trillion-revenue business, and the company is investing aggressively in AI infrastructure to keep up with growing demand. Amazon plans to spend a whopping $220 billion on capex this year, with that number expected to rise in 2027. It has a massive $496 billion backlog, with most of its capacity for next year already sold out. The company is getting a strong return on its investments. It says it will get a payback in two to three years, while signing five-year or more contracts, and its chip investments tend to have six-year useful lives.

Amazon also has a strong custom chip business, and I'd expect that its return profile could improve as it starts using more of its own chips. Back in April, Jassy said this was a $20 billion run rate business, or about $50 billion when including internal use. Amazon has partnerships with both Anthropic and OpenAI and looks well-positioned for continued strong AWS growth. Notably, it also holds a roughly 20% stake in Anthropic, which could be worth over $2 trillion in an IPO.

In addition to the strong growth Amazon is seeing with AWS, the company's e-commerce business continues to hum along. The business continues to post solid sales and has been seeing robust revenue growth from its high-margin sponsored ad business. The most impressive thing about its e-commerce operation, though, is the operating leverage it has realized from its investments in artificial intelligence (AI) and robotics. This is leading to profit growth nicely outpacing revenue growth.

Amazon also has some future growth opportunities that could become nice contributors by 2035. This includes its satellite internet service Amazon Leo, its autonomous vehicle subsidiary Zoox, and its new less-than-truckload freight venture.

Premium Feature

Moneyball Superscore

90/100

Today's Change

(

-0.58

%) $

-1.51

Current Price

$

258.41

Amazon is willing to invest big to win big, and that should translate into strong future growth. The last multi-analyst earnings per share (EPS) consensus for the company is for 2031, with analysts projecting EPS of $24.49, with a low estimate of $15.02 and a high estimate of $29.88.

Assuming Amazon grows its adjusted EPS by around 20% through 2034 and then 15% through 2036, the company would generate adjusted EPS of around $56.20 in 2036. The company has historically commanded a premium multiple, generally trading at a forward P/E of between 25 and 40, over the past couple of years. Apply a 25x multiple to the stock's projected 2026 EPS, and it could trade at $1,405. That's more than a 4.5-fold increase over the stock's current price.

At that multiple, an investment of just over $10,000 would be worth over $56,000 in 2035. Of course, Amazon may not achieve that type of adjusted EPS growth and/or its multiple could compress, but this is one of the best-run companies in the world, and its long-term upside looks substantial. I'd be a buyer of the stock.

Jeff Bezos said Wednesday that his rocket company, Blue Origin, will likely go public in several years.

The comments came after the company raised $10 billion from outside investors for the first time, reportedly valuing Blue Origin at $140 billion.

So far, Bezos has personally invested about $28 billion in Blue Origin since it launced in 2000. An IPO would eventually give the company access to public-market capital rather than relying primarily on Bezos’ wealth to finance its ambitions.

For Amazon.com, Inc. (NASDAQ:AMZN) shareholders, that distinction matters because Bezos’ space spending has historically been intertwined with his personal ownership of Amazon, which he also founded.

Although separate, Blue Origin and Amazon have a commercial relationship. For example, Seattle-based Amazon has contracts with Blue Origin for New Glenn launches that support a satellite broadband business called Amazon Leo.

Read Next

Amazon Could Get a Cleaner Space StoryAn eventual Blue Origin listing could make that relationship easier for investors to analyze.

Presently, Amazon investors have exposure to Amazon’s satellite ambitions through Amazon Leo, while Blue Origin remains a privately held company controlled by Bezos. A public listing would create a visible market valuation for Blue Origin, potentially giving investors a clearer benchmark for the value of the broader space ecosystem Bezos has spent decades building.

It could also change the way Bezos funds the company.

Instead of continually drawing on his personal wealth — historically supported in part by Amazon share sales — Blue Origin could raise capital directly from public investors. That could reduce the financial link between Bezos’ Amazon holdings and his space ambitions.

The IPO Could Create a New Space BenchmarkThe timing is particularly interesting because Elon Musk‘s Space Exploration Technologies Corp. (NASDAQ:SPCX) went public earlier this year, giving investors their first major public-market benchmark for a large private space company.

Blue Origin offers exposure to New Glenn, lunar ambitions, and government contracts with NASA and the U.S. Space Force. Bezos also said New Glenn will fly again in December after a launch-pad setback earlier this year.

For Amazon investors, the takeaway is not that Blue Origin’s potential IPO suddenly adds value to Amazon’s stock. It is that a public Blue Origin could finally separate the economics of Bezos’ space ambitions from Amazon — while simultaneously making Amazon’s own satellite business easier to compare with the emerging space market.

The next signals to watch are Blue Origin’s outside-capital strategy, New Glenn’s launch cadence and whether Bezos moves from saying an IPO "probably makes sense" to outlining a concrete path toward the public markets.

Read Next

Image via Shutterstock

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Kirtland Hills Capital Management LLC boosted its position in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 4.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 52,093 shares of the computer hardware maker’s stock after acquiring an additional 2,454 shares during the period. NVIDIA makes up approximately 3.0% of Kirtland Hills Capital Management LLC’s holdings, making the stock its 4th largest holding. Kirtland Hills Capital Management LLC’s holdings in NVIDIA were worth $10,423,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Bank of America Corp DE increased its position in shares of NVIDIA by 2.1% during the first quarter. Bank of America Corp DE now owns 191,200,989 shares of the computer hardware maker’s stock valued at $33,345,453,000 after purchasing an additional 4,019,505 shares during the period. Invesco Ltd. lifted its position in NVIDIA by 0.3% in the fourth quarter. Invesco Ltd. now owns 143,239,504 shares of the computer hardware maker’s stock worth $26,714,167,000 after purchasing an additional 446,178 shares during the period. J. Stern & Co. LLP boosted its stake in NVIDIA by 13,709.1% during the fourth quarter. J. Stern & Co. LLP now owns 125,760,307 shares of the computer hardware maker’s stock worth $23,454,297,000 after buying an additional 124,849,603 shares in the last quarter. Amundi boosted its stake in NVIDIA by 10.4% during the first quarter. Amundi now owns 133,768,018 shares of the computer hardware maker’s stock worth $23,329,141,000 after buying an additional 12,575,177 shares in the last quarter. Finally, Deutsche Bank AG increased its holdings in NVIDIA by 2.3% in the 2nd quarter. Deutsche Bank AG now owns 91,954,159 shares of the computer hardware maker’s stock valued at $18,399,108,000 after buying an additional 2,045,101 shares during the period. Institutional investors and hedge funds own 65.27% of the company’s stock.

More NVIDIA News Here are the key news stories impacting NVIDIA this week:

Positive Sentiment: SpaceX may become a major new customer. SpaceX is reportedly seeking approximately $40 billion in debt financing—potentially including bank loans and investment-grade bonds—to purchase NVIDIA GPUs for its AI infrastructure. The proposed transaction would reinforce demand for NVIDIA’s chips, although the debt-funded nature of the purchase raises questions about customer financing risk. Apollo, banks in talks to finance SpaceX’s $40 billion Nvidia GPU purchase Positive Sentiment: NVIDIA is expanding beyond data centers into PCs and edge AI. Microsoft unveiled the $2,599 Surface Laptop Ultra with an NVIDIA AI chip, while ASUS and other manufacturers began offering RTX Spark-powered systems for local AI workloads. This could broaden NVIDIA’s addressable market and create a new consumer and enterprise revenue stream. Microsoft to sell Surface Laptop Ultra containing Nvidia AI chip Positive Sentiment: AI infrastructure adoption remains widespread. NVIDIA-backed Lambda is reportedly targeting up to $4 billion in additional funding ahead of a planned IPO, while robotics, sovereign-AI and cloud-computing companies continue announcing deployments using NVIDIA platforms. These developments support the company’s ecosystem and long-term demand outlook. Nvidia-backed Lambda targets $4 billion raise Positive Sentiment: Analyst sentiment remains bullish. Morgan Stanley raised its price target, and consensus estimates cited by analysts imply additional upside. NVIDIA’s prior quarterly earnings beat and more-than-doubling revenue growth continue to support the bullish case. Neutral Sentiment: Market conditions are mixed. Rising oil prices tied to renewed Strait of Hormuz tensions pressured broader equities, while investors also remained focused on interest rates and Federal Reserve minutes. Negative Sentiment: Valuation and concentration risks are becoming more prominent. NVIDIA is approaching a $6 trillion market capitalization after a powerful rally, increasing the potential for profit-taking. Michael Burry has reportedly shifted to longer-dated put options on NVIDIA, citing the risk of an eventual AI downturn. Negative Sentiment: Trade and execution risks could weigh on the shares. Fresh tariff threats and concerns about margin compression, inventory levels and the sustainability of debt-financed AI spending are tempering enthusiasm. Investors may also be reluctant to chase the stock near record highs without evidence that earnings growth can continue to exceed elevated expectations. NVIDIA Stock Down 0.8% Shares of NASDAQ:NVDA opened at $237.36 on Thursday. The company’s fifty day moving average is $221.38 and its 200-day moving average is $208.88. The company has a debt-to-equity ratio of 0.14, a quick ratio of 3.85 and a current ratio of 4.59. NVIDIA Corporation has a 52 week low of $164.27 and a 52 week high of $243.37. The company has a market capitalization of $5.72 trillion, a PE ratio of 30.01, a P/E/G ratio of 1.85 and a beta of 2.22. NVIDIA (NASDAQ:NVDA – Get Free Report) last announced its earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The business had revenue of $96.22 billion during the quarter, compared to analysts’ expectations of $92.27 billion. During the same quarter last year, the company posted $1.05 EPS. The firm’s revenue for the quarter was up 105.9% on a year-over-year basis. Equities research analysts predict that NVIDIA Corporation will post 9.25 earnings per share for the current fiscal year.

NVIDIA announced that its Board of Directors has authorized a share buyback plan on Monday, September 28th that allows the company to repurchase $150.00 billion in shares. This repurchase authorization allows the computer hardware maker to purchase up to 2.8% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board believes its stock is undervalued.

NVIDIA Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Thursday, September 10th were paid a $0.25 dividend. The ex-dividend date was Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. NVIDIA’s payout ratio is 12.64%.

Insider Activity In other news, Director Mark Stevens sold 622,239 shares of the business’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $231.62, for a total value of $144,122,997.18. Following the transaction, the director directly owned 2,336,531 shares of the company’s stock, valued at $541,187,310.22. The trade was a 21.03% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Timothy Teter sold 30,460 shares of the stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $222.80, for a total value of $6,786,488.00. Following the sale, the executive vice president owned 2,687,660 shares in the company, valued at approximately $598,810,648. This trade represents a 1.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 1,766,118 shares of company stock worth $399,450,353. Insiders own 3.94% of the company’s stock.

Analyst Upgrades and Downgrades A number of equities analysts have recently issued reports on the stock. Daiwa Securities Group dropped their price objective on shares of NVIDIA from $255.00 to $245.00 and set an “outperform” rating for the company in a research note on Thursday, September 17th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of NVIDIA in a research report on Monday, August 31st. BNP Paribas Exane reissued an “outperform” rating and issued a $345.00 target price on shares of NVIDIA in a research note on Monday. Morgan Stanley set a $230.00 price target on shares of NVIDIA in a research report on Friday, October 2nd. Finally, JPMorgan Chase & Co. raised their price target on shares of NVIDIA from $280.00 to $320.00 and gave the stock an “overweight” rating in a research note on Thursday, August 27th. Four analysts have rated the stock with a Strong Buy rating, fifty have issued a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, NVIDIA presently has an average rating of “Buy” and an average price target of $321.89.

View Our Latest Report on NVDA

NVIDIA Profile (Free Report)

NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.

The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.

Featured Articles Five stocks we like better than NVIDIA Skydance Just Became a Media Giant—With an $80 Billion Debt Load Could Velo3D Be the Next Defense Buyout Target? Penguin Solutions Is Soaring as AI Memory Demand Explodes Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).

Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.

The heat is on for artificial intelligence (AI) companies. After mind-blowing growth over the past few years, some AI developers have been sounding the alarm over the technology's risks. Anthropic, whose CEO, Dario Amodei, has moved to the forefront of the initiative to slow things down, postponed its initial public offering (IPO) from the initially expected September or October to November, and many executives across the AI space have joined in the call for greater care in model development.

AI stocks as a group fell after Amodei's note went viral in mid-September, although that seems to have been a short-term reaction. More pressing is how a slowdown in AI model development would impact hardware companies like Nvidia (NVDA -0.53%). Here's how CEO Jensen Huang reacted, and what investors can expect for Nvidia.

Doomsday narrative and AI growth The public's fears over the risks AI poses intensified to a new level in September when an Anthropic AI researcher quit the company and publicized the reason why on social media, claiming that at its current pace, he believed that unchecked AI development was putting humanity at risk of extinction within the next decade.

Nvidia CEO Jensen Huang. Image source: Getty Images.

While AI leaders like Amodei, OpenAI's Sam Altman, and Elon Musk chimed in to agree that there were real dangers, Huang took a completely different spin.

"2030 is not going to be the end of the world," he told CBS News in an interview. "There is 0% chance that's going to be the end of the world. Scaring people is unnecessary. It is irresponsible."

While that kind of response seems to argue in favor of AI developers and hyperscalers continuing along a build-out path that would benefit Nvidia, Huang rejected the notion that his opinion might be biased by that.

"Our company's success is directly connected to the safe deployment of products and services," he noted. "If we don't continue to do that, our value would be diminished."

How Nvidia fits in Nvidia has been arguably the most important and successful player in the AI revolution. It has expanded from a relatively obscure chip designer into the most valuable company in the world, and the only one worth more than $5 trillion.

Premium Feature

Moneyball Superscore

95/100

Today's Change

(

-0.53

%) $

-1.25

Current Price

$

236.22

Its 11-fold growth over the past five years has come from the unrelenting demand for its best-in-class graphics processing units (GPUs), the chips that provide the parallel-processing power required to drive generative AI. Revenue hasn't just increased at high rates, it has recently accelerated again, which is a feat considering the much larger base it's now comparing that growth to. Even more, it has developed complete computing platforms for training and inference, filling data centers with high-level technology. It's clear that a slowdown in AI development would damage Nvidia's growth prospects.

Nvidia stock fell after the warnings a few weeks ago, but it has bounced back and hit a new high this week. Nvidia hasn't joined the chorus calling for an AI development slowdown, nor has it changed its guidance, and Wall Street expects a 91% year-over-year increase in revenue in the current quarter. The market seems to be on board with Huang, and that's crucial for Nvidia's growth story.

In its upcoming report, JPMorgan Chase & Co. (JPM - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $5.94 per share, reflecting an increase of 17.2% compared to the same period last year. Revenues are forecasted to be $52.21 billion, representing a year-over-year increase of 12.5%.

The consensus EPS estimate for the quarter has undergone an upward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.

That said, let's delve into the average estimates of some JPMorgan Chase & Co. metrics that Wall Street analysts commonly model and monitor.

Analysts predict that the 'Book value per share' will reach $134.63 . Compared to the current estimate, the company reported $124.96 in the same quarter of the previous year.

According to the collective judgment of analysts, 'Average Balances - Total interest-earning assets' should come in at $4352.63 billion. Compared to the present estimate, the company reported $3895.76 billion in the same quarter last year.

Analysts forecast 'Total nonperforming assets' to reach $11.29 billion. Compared to the current estimate, the company reported $10.64 billion in the same quarter of the previous year.

It is projected by analysts that the 'Total nonaccrual loans' will reach $10.40 billion. The estimate is in contrast to the year-ago figure of $10.11 billion.

The consensus estimate for 'Tier 1 Capital Ratio - Standardized' stands at 15.0%. Compared to the present estimate, the company reported 15.8% in the same quarter last year.

Analysts expect 'Net Interest Income- managed' to come in at $26.84 billion. The estimate compares to the year-ago value of $24.07 billion.

Based on the collective assessment of analysts, 'Noninterest revenue- Investment banking fees' should arrive at $3.04 billion. Compared to the present estimate, the company reported $2.61 billion in the same quarter last year.

The combined assessment of analysts suggests that 'Noninterest revenue- Principal transactions' will likely reach $7.33 billion. Compared to the present estimate, the company reported $7.11 billion in the same quarter last year.

The consensus among analysts is that 'Total Noninterest revenue' will reach $24.74 billion. The estimate is in contrast to the year-ago figure of $22.46 billion.

The average prediction of analysts places 'Net Interest Income' at $26.96 billion. The estimate is in contrast to the year-ago figure of $23.97 billion.

Analysts' assessment points toward 'Noninterest revenue- Card income' reaching $1.24 billion. The estimate is in contrast to the year-ago figure of $1.14 billion.

The collective assessment of analysts points to an estimated 'Noninterest revenue- Lending- and deposit-related fees' of $2.52 billion. Compared to the current estimate, the company reported $2.35 billion in the same quarter of the previous year.

View all Key Company Metrics for JPMorgan Chase & Co. here>>>

Over the past month, JPMorgan Chase & Co. shares have recorded returns of -7.1% versus the Zacks S&P 500 composite's +1.4% change. Based on its Zacks Rank #3 (Hold), JPM will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Johnson & Johnson (JNJ -1.99%) has many qualities. It is one of the largest healthcare companies in the world and boasts an incredibly diversified business and an AAA rating from S&P Global, the highest rating available. However, whatever one might say about Johnson & Johnson, the company is hardly a good pick for growth-oriented investors. Still, the drugmaker may improve sales and earnings growth over the next few years, and by 2030, it may be growing faster than many expect. Here is why.

Image source: The Motley Fool.

Johnson & Johnson has made important changes Johnson & Johnson is a diversified healthcare player, but it used to be even more so. The company had a consumer health business through which it offered various over-the-counter healthcare products. Many of them were fairly well-known brands. However, this was a mature business that typically grew its sales more slowly than Johnson & Johnson's two other segments: biopharma and medtech.

So, Johnson & Johnson decided to get rid of it. The company completed the separation of its consumer health division, which became a stand-alone, publicly traded company, in 2023. It may already have had a positive impact on Johnson & Johnson. Removing the slower-growth business has arguably helped lift top-line growth somewhat. In fact, immediately after the separation, Johnson & Johnson slightly raised its growth outlook for the fiscal year 2023.

However, there is something else to consider. Johnson & Johnson can now focus its investments on its two core, faster-growing business units. That could eventually allow the company to launch more innovative and lucrative products within these two divisions, leading to even faster revenue and earnings growth. This isn't the sort of thing that can happen overnight. But over the next few years, we could see that story unraveling before our very eyes. That's one reason Johnson & Johnson could grow faster than many expect by 2030.

Premium Feature

Moneyball Superscore

80/100

Today's Change

(

-1.99

%) $

-5.15

Current Price

$

253.31

The medtech business could be key Johnson & Johnson's biopharma business is performing well and has recently won important new approvals, including that of ICOTYDE, a medicine for plaque psoriasis. However, the company's medtech segment could also make significant progress over the next few years, partly due to the recent approval of its Ottava robotic surgery system. The U.S. Food and Drug Administration cleared the Ottava for multiple soft tissue procedures in general surgery.

Johnson & Johnson will be competing with the market leader, Intuitive Surgical (ISRG -0.19%), in the robotic surgery space. However, there is a vast opportunity in this field. As Johnson & Johnson points out, fewer than 8% of relevant eligible procedures are performed robotically. Johnson & Johnson plans to seek clearance for Ottava elsewhere and should also pursue other indications. It will take some time to ramp up sales of this device, but Tim Schmid, the company's executive vice president and chairman of medtech, expects that Ottava will make a meaningful financial impact by the end of the decade.

Perhaps that's too optimistic, but the Ottava could eventually become a meaningful growth driver. Meanwhile, Johnson & Johnson is separating its lower-growth orthopedics division into a stand-alone company, which should help boost sales growth within its medtech business once the separation is complete.

Some risks to consider Johnson & Johnson's medium-term prospects look attractive, but there are some risks to consider, including some that could harm revenue and earnings growth. For instance, the company is dealing with government-led price negotiations in the U.S., and while it is handling the issue well right now, things could worsen on that front over the next few years.

Further, Johnson & Johnson still has to contend with thousands of lawsuits alleging that its talc-based products gave plaintiffs cancer. But the company has made progress on that front. It recently proposed a $5.5 billion settlement (contingent on certain conditions) that could help it put most of these lawsuits to bed.

Turning to government price negotiations, the company's deep pipeline and diversified drug portfolio could help it continue to overcome that obstacle. Finally, Johnson & Johnson is a fantastic dividend stock, boasting a streak of 64 consecutive annual payout increases, making it a Dividend King (a title for companies with at least 50 consecutive annual dividend increases). All good reasons why the stock is a buy

Delta Air Lines (NYSE:DAL) looks to carry momentum forward as one of the few airlines up in share price since the U.S.-Iran war began. The company reports third-quarter financial results Friday before the market opens.

Analysts expect third-quarter revenue of $17.64 billion, up from $16.67 billion a year earlier, according to Benzinga Pro data. The company has beaten revenue estimates in 23 straight quarters.

Analysts also expect earnings per share of $1.85, up from $1.71. Delta has topped EPS estimates in seven of the last 10 quarters, including the second quarter.

Delta Analyst RatingsAnalysts have been lowering their price targets on Delta stock in recent weeks. Here are some of the most recent analyst ratings on Delta stock and their price targets:

Bernstein: Maintained Outperform rating, lowered price target from $106 to $100 Susquehanna: Maintained Positive rating, lowered price target from $105 to $100 Wells Fargo: Maintained Overweight rating, lowered price target from $105 to $100 TD Cowen: Maintained Buy rating, lowered price target from $105 to $101 Key Items to WatchDelta reported a strong second quarter with passenger revenue up 13% year-over-year, including premium-product revenue up 17% year-over-year. Investors and analysts will want to see similar growth for the third quarter.

Read Next

The key item to watch outside of overall revenue will be fuel costs, which are one of the largest costs for an airline company.

Rising oil prices are proving to be a negative catalyst for the airline sector. In the second quarter, adjusted fuel expenses rose 77% year-over-year for Delta, marking the highest quarterly fuel expense in company history.

Despite the increased costs, Delta reaffirmed its full-year outlook for earnings, highlighting the company’s momentum and ability to offset the higher fuel costs.

Analysts and investors will look for similar commentary in Q3, including guidance for the rest of the current fiscal year and perhaps an early read on the next fiscal year.

Unlike other large airline stocks, Delta shares are up year-to-date, with a current 20.1% return. By comparison, its peers —American Airlines (NASDAQ:AAL), United Airlines (NASDAQ:UAL) and Southwest Airlines (NYSE:LUV) — are down 17.8%, 3.5% and 0.3% respectively, in 2026.

The US Global Jets ETF (NYSE:JETS), which tracks the airline sector, is down 2.4% year-to-date in 2026. Delta is the second-largest position, at 11.3% of assets.

A strong report from Delta could help boost the airline sector overall.

Delta Air Lines Stock Price ActionDelta stock is down 0.4% to $82.63 on Thursday versus a 52-week trading range of $55.03 to $95.68.

Read Next

Photo: kamilpetran/Shutterstock

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Key Takeaways Moderna will join the Nasdaq-100 after a sharp rise in market value and growing business optimism.Positive phase III cancer therapy results have strengthened confidence in Moderna's mRNA platform.Index-linked funds could create incremental demand for Moderna shares, though fundamentals remain unchanged. Moderna (MRNA - Free Report) shares are set to join the Nasdaq-100 Index on Oct. 9, marking another milestone for the biotech after its sharp gains this year. The company will replace Warner Bros. Discovery in the index before the opening bell on Friday.

The change comes after the recent completion of Paramount’s acquisition of Warner Bros. Discovery, whose shares have now ceased trading. The combined entity has been named Skydance (SKYD - Free Report) following the transaction and recently started trading on the NYSE.

Why Is Moderna Being Added to the Nasdaq-100?While Nasdaq has not cited any specific factor behind Moderna’s addition, its inclusion comes after a sharp increase in the company’s market value and growing optimism around its business prospects. The Nasdaq-100 is widely regarded as a large-cap growth index, with Nasdaq describing it as a benchmark focused on innovation and growth. Its constituents span several industries, including healthcare, alongside its strong technology representation. This makes Moderna’s addition notable as the company seeks to establish itself as a growth-oriented biotech beyond its legacy as a COVID-19 vaccine maker.

Moderna’s improving prospects have primarily been supported by positive phase III results for its personalized cancer therapy, which is being developed in collaboration with Merck (MRK - Free Report) . The study met its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival in certain patients with high-risk melanoma. The results have strengthened investor confidence in the potential of Moderna’s mRNA platform beyond vaccines. The stock’s strong performance following the results likely helped support its eligibility for inclusion in the Nasdaq-100.

The inclusion could also create a more direct benefit for MRNA through the investment products linked to the index. Per Nasdaq, the Nasdaq-100 is tracked by more than 200 investment products with over $800 billion in assets under management globally. As funds and other products tracking the benchmark adjust their portfolios following changes in its constituents, Moderna could see incremental institutional demand for its shares.

However, the inclusion does not change Moderna’s underlying fundamentals. It has no direct impact on the company’s operations, cash flow or pipeline development. Any benefit from the inclusion is likely to be more technical and demand-driven, as index-tracking funds may need to buy MRNA and adjust their portfolios. The stock’s longer-term performance will continue to depend on Moderna’s underlying business and pipeline.

MRNA’s Price Performance, Valuation & EstimatesShares of Moderna have skyrocketed 566% year-to-date, significantly outperforming the industry’s 1% growth.

Image Source: Zacks Investment Research

From a valuation standpoint, the company is currently trading at a premium to the industry. Based on the price-to-sales (P/S) ratio, the stock trades at 30.84 times forward 12-month sales, higher than the industry average of 2.06 times.

Image Source: Zacks Investment Research

Estimates for Moderna’s 2026 and 2027 loss per share have improved over the past 60 days.

Image Source: Zacks Investment Research

Moderna currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Pfizer (PFE -1.45%) is offering a dividend yield of roughly 6% today. That is well above the roughly 1% yield on offer from the S&P 500 index (^GSPC -0.34%) and the 1.4% average yield of pharmaceutical stocks. There are good reasons for the negative view of Pfizer, but investors may be ignoring the company's over 100-year history of success. Here's why you may want to consider buying this out-of-favor dividend stock while others are fearful.

Pfizer is facing normal industry headwinds Pfizer's stock rocketed higher during the coronavirus pandemic, as investors myopically focused on the company's COVID vaccine. When COVID turned out to be a less serious long-term threat than originally believed, Wall Street dumped Pfizer. At this point, the stock is down more than 50% from its 2021 high. That is a big part of the story behind the high yield.

Image source: Getty Images.

However, there's another piece that is more fundamental to the pharmaceutical industry. Like all drug makers, Pfizer's drugs receive time-limited patent protections. When patents expire, generic versions of the medications can be produced. That generally leads to a dramatic decline in revenue from Pfizer's drugs. Right now, Pfizer is facing down some notable patent expirations. This is a completely normal dynamic in the pharmaceutical sector.

Patent expirations are why drug companies are always on the lookout for new drugs. The problem is that patent expirations follow a set schedule, but drug development does not. Pfizer's drug pipeline isn't producing major new drugs right now, and it looks like it may have to work through a period in which new drugs won't fully offset revenue lost to patent expirations. This isn't uncommon, either, but investors are likely focusing on the short term rather than the long term when it comes to Pfizer.

Pfizer fumbles the GLP-1 opportunity A key driver of Wall Street's negativity is probably the GLP-1 weight-loss opportunity. Pfizer isn't even in the race yet, after one of its own drugs flamed out. No wonder the company's price-to-forward-earnings ratio is below 10x, while Eli Lilly (LLY -3.70%), the leader in the GLP-1 space, has a price-to-forward P/E of 24x.

To Pfizer's credit, however, it moved quickly to address its GLP-1 shortfall, buying a company with an attractive weight-loss drug still in development. It is also advancing a number of other drugs, notably in the cancer space, which is an extremely large treatment area. History suggests the company is dealing with a timing issue, not a fundamental shortfall of its business. Given enough time, Pfizer is highly likely to get back on track.

Premium Feature

Moneyball Superscore

65/100

Today's Change

(

-1.45

%) $

-0.41

Current Price

$

27.60

Will Pfizer's 6% yield survive? Pfizer's management has stated clearly that it intends to support the dividend. In fact, the goal is to grow the dividend over the long term. Moreover, the company ended the second quarter with more than $11 billion in cash on its balance sheet, providing ample liquidity to support its business and dividend. While its dividend payout ratio is troublingly high, its cash dividend payout ratio is roughly 90%, so it still has the cash flow to cover the payout. (Dividends are paid out of cash flow, not earnings, which is why the financial impact of dividends is found on the cash flow statement.)

Given that Pfizer is facing patent expirations without new drugs to replace the income it will lose, there is clearly a near-term risk. That includes a risk that the dividend could be cut. However, even with a 50% dividend cut, the yield would remain attractively high. And given the stock price, you could easily argue a cut has already been priced in. Meanwhile, the company's long history of success suggests that it will eventually work through this period. More aggressive dividend investors may want to give it the benefit of the doubt, with the worst-case scenario likely being a still above-market and peer yield.

, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Kinross Gold Corporation ("Kinross" or the "Company") (NYSE: KGC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Kinross and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On September 23, 2026, Kinross issued a press release "provid[ing] an operational, guidance and return of capital update."  Specifically, Kinross advised that "[t]he Company now expects full-year 2026 and 2027 attributable production to be 2% to 3% below the low end of the previously disclosed guidance, with approximately 1.84 to 1.86 million gold equivalent ounces ('Au eq. oz.') expected per year.  The change to the Company's 2026 guidance is concentrated at two smaller assets, La Coipa and Round Mountain, and is the result of extreme weather and operational challenges." 

On this news, Kinross's stock price fell $3.20 per share, or 11.59%, to close at $24.42 per share on September 24, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes. 

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP

Analysts on Wall Street project that Wells Fargo (WFC - Free Report) will announce quarterly earnings of $1.85 per share in its forthcoming report, representing an increase of 6.9% year over year. Revenues are projected to reach $22.15 billion, increasing 3.3% from the same quarter last year.

The current level reflects an upward revision of 1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.

That said, let's delve into the average estimates of some Wells Fargo metrics that Wall Street analysts commonly model and monitor.

The consensus estimate for 'Average Balance - Total interest-earning assets' stands at $2089.78 billion. Compared to the current estimate, the company reported $1832.51 billion in the same quarter of the previous year.

According to the collective judgment of analysts, 'Book value per common share' should come in at $54.96 . Compared to the current estimate, the company reported $52.30 in the same quarter of the previous year.

Based on the collective assessment of analysts, 'Return on equity (ROE) - Financial Ratios' should arrive at 13.5%. The estimate compares to the year-ago value of 12.8%.

Analysts predict that the 'Efficiency Ratio' will reach 62.5%. Compared to the current estimate, the company reported 65.0% in the same quarter of the previous year.

Analysts forecast 'Total nonperforming assets' to reach $8.47 billion. The estimate compares to the year-ago value of $7.83 billion.

The average prediction of analysts places 'Total nonaccrual loans' at $8.17 billion. Compared to the present estimate, the company reported $7.61 billion in the same quarter last year.

Analysts expect 'Net loan charge-offs' to come in at $985.61 million. The estimate compares to the year-ago value of $942.00 million.

The consensus among analysts is that 'Common Equity Tier 1 (CET1) - Standardized Approach' will reach 10.1%. The estimate compares to the year-ago value of 11.0%.

The combined assessment of analysts suggests that 'Tier 1 Leverage Ratio' will likely reach 6.8%. The estimate compares to the year-ago value of 7.7%.

It is projected by analysts that the 'Tier 1 Capital Ratio - Standardized Approach' will reach 11.3%. Compared to the present estimate, the company reported 12.3% in the same quarter last year.

Analysts' assessment points toward 'Net Interest Income' reaching $12.63 billion. The estimate compares to the year-ago value of $11.95 billion.

The collective assessment of analysts points to an estimated 'Total Noninterest Income' of $9.59 billion. The estimate compares to the year-ago value of $9.49 billion.

View all Key Company Metrics for Wells Fargo here>>>

Over the past month, shares of Wells Fargo have returned -10.5% versus the Zacks S&P 500 composite's +1.4% change. Currently, WFC carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Have you evaluated the performance of Costco's (COST - Free Report) international operations for the quarter ending August 2026? Given the extensive global presence of this warehouse club operator, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.

In the modern, closely-knit global economic landscape, the capacity of a business to access foreign markets is often a key determinant of its financial well-being and growth path. Investors now place great importance on grasping the extent of a company's dependence on international markets, as it sheds light on the firm's earnings stability, its skill in leveraging various economic cycles and its broad growth potential.

Being present in foreign markets serves as protection against local economic declines and helps benefit from more rapidly expanding economies. Yet, such expansion also introduces challenges related to currency fluctuations, geopolitical uncertainties and varied market behaviors.

In our recent assessment of COST's quarterly performance, we discovered notable trends in its overseas revenue sections, which are typically modeled and scrutinized by Wall Street analysts.

For the quarter, the company's total revenue amounted to $95.72 billion, experiencing an increase of 11.1% year over year. Next, we'll explore the breakdown of COST's international revenue to understand the importance of its overseas business operations.

A Look into COST's International Revenue StreamsOther International accounted for 13.6% of the company's total revenue during the quarter, translating to $13.05 billion. Revenues from this region represented a surprise of +2.04%, with Wall Street analysts collectively expecting $12.79 billion. When compared to the preceding quarter and the same quarter in the previous year, Other International contributed $9.68 billion (13.7%) and $12.03 billion (14%) to the total revenue, respectively.

During the quarter, Canada contributed $12.79 billion in revenue, making up 13.4% of the total revenue. When compared to the consensus estimate of $13.17 billion, this meant a surprise of -2.94%. Looking back, Canada contributed $9.41 billion, or 13.3%, in the previous quarter, and $11.9 billion, or 13.8%, in the same quarter of the previous year.

Projected Revenues in Foreign MarketsIt is projected by analysts on Wall Street that Costco will post revenues of $73.87 billion for the ongoing fiscal quarter, an increase of 9.8% from the year-ago quarter. The expected contributions from Other International and Canada to this revenue are 14.2%, and 13.6%, translating into $10.51 billion, and $10.01 billion, respectively.

For the full year, a total revenue of $328.37 billion is expected for the company, reflecting an increase of 8.3% from the year before. The revenues from Other International and Canada are expected to make up 14%, and 13.5% of this total, corresponding to $45.82 billion, and $44.22 billion, respectively.

In ConclusionRelying on international markets for revenues, Costco faces both prospects and perils. Thus, tracking the company's international revenue trends is essential for accurately projecting its future trajectory.

In an era of growing international interdependencies and escalating geopolitical disputes, Wall Street analysts are vigilant in tracking these trends for businesses with a global reach, in order to refine their predictions of earnings. It should be noted, however, that a multitude of other elements, such as a company's domestic position, also play a significant role in shaping the earnings forecasts.

At Zacks, we place significant importance on a company's evolving earnings outlook. This is based on empirical evidence demonstrating its strong influence on a stock's short-term price movements. Invariably, there exists a positive relationship -- an upward revision in earnings estimates is typically mirrored by a rise in the stock price.

Boasting a remarkable track record that's been externally verified, the Zacks Rank, our unique stock rating system, leverages changes in earnings projections to function as a reliable gauge for predicting short-term stock price movements.

Costco currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Assessing Costco's Stock Price Movement in Recent TimesThe stock has increased by 4.4% over the past month compared to the 1.4% increase of the Zacks S&P 500 composite. Meanwhile, the Zacks Retail-Wholesale sector, which includes Costco,remained unchanged during this time frame. Over the past three months, the company's shares have experienced a gain of 2.8% relative to the S&P 500's 4% increase. Throughout this period, the sector overall remained unchanged.